Shopping Cart
- Remove All
Your shopping cart is currently empty
LEI-106 is an effective dual inhibitor of DAGL-α (sn-1-Diacylglycerol lipase α) and ABHD6 (α/β-hydrolase domain 6), with Ki values of 0.7 and 0.8 μM respectively, suitable for obesity and metabolic syndrome research.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $163 | 35 days | |
| 5 mg | $482 | 35 days | |
| 10 mg | $848 | 35 days | |
| 25 mg | $1,830 | 35 days |
| Description | LEI-106 is an effective dual inhibitor of DAGL-α (sn-1-Diacylglycerol lipase α) and ABHD6 (α/β-hydrolase domain 6), with Ki values of 0.7 and 0.8 μM respectively, suitable for obesity and metabolic syndrome research. |
| Targets&IC50 | ABHD6:0.8 μM (Ki), DAGLα:18 nM |
| In vivo | Methods: LEI-106 (40 mg/kg) was administered to female SD rats via intraperitoneal injection to investigate the effects of LEI-106 on the integrity of the blood-brain barrier (BBB). Result: LEI-106 reduced 2-AG levels by inhibiting DAGLα, thereby impairing the blood-brain barrier's integrity.[2] |
| Synonyms | t-Boc-N-amido-PEG4-NHS ester |
| Molecular Weight | 481.56 |
| Formula | C26H27NO6S |
| Cas No. | 1620582-23-1 |
| Smiles | CC1(C)OC=2C(=CC(S(N(CC3=CC=C(OC4=CC=CC=C4)C=C3)CC(O)=O)(=O)=O)=CC2)CC1 |
| Relative Density. | 1.288 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.